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Extracellular calcium is a major regulator of keratinocyte differentiation in vitro and appears to play that role in vivo, but the
mechanism is unclear. We have previously demonstrated that, following calcium stimulation, PIP5K1𝛼 is recruited by the E-
cadherin-𝛽-catenin complex to the plasmamembranewhere it provides the substrate PIP2 for both PI3K and PLC-𝛾1.This signaling
pathway is critical for calcium-induced generation of second messengers including IP3 and intracellular calcium and keratinocyte
differentiation. In this study, we explored the upstream regulatory mechanism by which calcium activates PIP5K1𝛼 and the role of
this activation in calcium-induced keratinocyte differentiation. We found that treatment of human keratinocytes in culture with
calcium resulted in an increase in serine dephosphorylation andPIP5K1𝛼 activation. PP1 knockdownblocked extracellular calcium-
induced increase in serine dephosphorylation and activity of PIP5K1𝛼 and induction of keratinocyte differentiation markers.
Knockdown of PLC-𝛾1, the downstream effector of PIP5K1𝛼, blocked upstreamdephosphorylation and PIP5K1𝛼 activation induced
by calcium. Coimmunoprecipitation revealed calcium induced recruitment of PP1 to the E-cadherin-catenin-PIP5K1𝛼 complex in
the plasma membrane. These results indicate that PP1 is recruited to the extracellular calcium-dependent E-cadherin-catenin-
PIP5K1𝛼 complex in the plasma membrane to activate PIP5K1𝛼, which is required for PLC-𝛾1 activation leading to keratinocyte
differentiation.
1. Introduction
The integral role of calcium in keratinocyte differentiation
and in the regulation of epidermal functions is well estab-
lished [1–8]. Disturbance of calcium homeostasis and aber-
rant keratinocyte differentiation and/or epidermal barrier
dysregulation have been implicated in various skin patholo-
gies [9–15], but the mechanism is not fully understood. We
have previously proposed a possible signaling pathway that
involves the extracellular calcium-induced recruitment of
PI3K, PLC-𝛾1, and PIP5K1𝛼 leading to keratinocyte differen-
tiation [16–19].
Epidermal keratinocytes have been shown to go through
a terminal differentiation phase as they migrate from stratum
basale to stratum corneum [20].These in vitro differentiation
processes can be reproduced by culturing keratinocytes in
media with high calcium concentration, and these events
closely resemble those of terminal differentiation of ker-
atinocytes in vivo [1, 3, 5, 6]. In culture, keratinocytes mor-
phologically resemble basal epidermal cells and fail to dif-
ferentiate in calcium concentrations less than 0.03mM. But
at calcium concentrations exceeding 0.1mM, keratinocytes
morphologically resemble suprabasal epidermal cells and
achieve the capability to differentiate [2]. Keratinocyte dif-
ferentiation involves an intricate pathway involving cell-cell
adhesion [3] and raised intracellular free calcium level [21]
as a consequence of calcium release from internal stores
and calcium influx through calcium channels in the plasma
membrane [22], both of which are triggered by the increased
extracellular calcium level. Extracellular calciumbrings about
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the redistribution of cell adhesionmolecules from the cytosol
to the plasma membrane and the formation of intercellular
contacts [3, 23]. The elevation of extracellular calcium results
in an acute and sustained rise of intracellular calcium in the
keratinocytes [24, 25] in the presence of PIP5K1𝛼 [19], both
of which are prerequisites for calcium-induced keratinocyte
differentiation [19, 26].
The role of phosphoprotein phosphatases and protein
kinases in cellular functions and signal transduction path-
ways is well-known [27, 28]. Phosphoprotein phosphatase
1 (PP1) is a major serine/threonine phosphatase of the
phosphoprotein phosphatase family [29]. Among the four
major protein serine/threonine phosphatases, PP1 and PP2A
are the two main ones that regulate diverse cellular events
[30–32]. Other members of this superfamily include PP2B
(calcineurin, PP3) [33]. PP1 is composed of the catalytic
subunit and a wide variety of targeting/regulatory subunits
[31, 32]. Four isoforms of the catalytic subunit of PP1,
namely, 𝛼, 𝛾1, 𝛾2, and 𝛿, have similar properties [33] and
are expressed in mammalian tissues [34–38]. The intricate
balance of phosphorylation by kinases and dephosphory-
lation by phosphatases is essential for maintaining signal
transduction networks in cells [39]. PP1 is essential in many
cellular events including calcium signaling [40] and has been
regarded as a key player in the regulation of inositol-1,4,5-
triphosphate receptor- (IP3R-) dependent calcium signaling
[41]. IP3R acts as a calcium channel that releases calcium
stored in the endoplasmic reticulum to the cytoplasm [42].
In one study, PP1 inhibition by okadaic acid reduced calcium
levels [43]. Knockdown of PIP5K1𝛼 blocks calcium-induced
PIP
2
and IP
3
production, intracellular calcium rise, and
keratinocyte differentiation. PIP5K1𝛼 has been shown to be
activated by dephosphorylation via protein kinase C (PKC)
activated PP1. The possible role of PP1 in the stimulation of
PIP5K1𝛼 synthesis by calcium to sustain IP
3
production and
keratinocyte differentiation cannot be overlooked. In light of
this, we hypothesized that PP1 may play a role in the regu-
lation of calcium release, thereby affecting the extracellular
calcium-induced activation of PIP5K1𝛼 and having an impact
on the calcium-induced PIP
2
synthesis, PLC-𝛾1 activation,
and IP
3
production, eventually leading to keratinocyte differ-
entiation. To test this hypothesis, we examined the effect of
PP1 knockdown on keratinocyte differentiation induced by
calcium.
2. Materials and Methods
2.1. Cell Culture. Human keratinocytes were isolated from
neonatal human foreskins from the Department of Urol-
ogy of The Second Xiangya Hospital of Central South
University as done previously [44]. Primary cultures were
established in serum-free medium (medium 154CF with
human keratinocyte growth supplement, Cascade Biologics,
Portland, OR) containing 0.07mM calcium and second
passage human keratinocytes were plated in serum-free
medium containing 0.03mM calcium and used in further
experiments.
2.2. Small Interfering RNA Transfection. Keratinocytes with
10% confluence were transfected with small interfering RNA
(siRNA) for E-cadherin, 𝛽-catenin, PIP5K𝛼, or negative
control (ON-TARGET plus siRNA, Dharmacon, Chicago,
IL) at a concentration of 100 nM using TransIT-siQUEST
transfection reagent (Mirus, PanVera Corp., Madison, WI)
at a dilution of 1 : 750 in accordance with the manufacturer’s
protocol.
2.3. Cell Lysate Preparation, Western Analysis, and Coim-
munoprecipitation. Total cell lysates were isolated, for which
PBS containing 2% SDS, complete protease inhibitors
(Roche Applied Science), and 4-(2-aminoethyl) benzenesul-
fonyl fluoride (EMD Biosciences, CA) was used. Plasma
membrane lysates were isolated using Mem-PER Eukary-
otic Membrane Protein Extraction Reagent Kit (Pierce
Biotechnology, Inc., Rockford, IL). The bicinchoninic acid
(BCA) Protein Assay Kit (Pierce Biotechnology, Inc.) was
used to measure the protein concentration of the lysate.
Equal amounts of protein were electrophoresed, reduc-
ing SDS-PAGE, and electroblotted onto polyvinylidene
fluoride (PVDF) membranes (Immobilon-P, 0.45𝜇M, Milli-
pore). After incubation in blocking buffer (100mMTris base,
150mM NaCl, 5% nonfat milk, and 0.5% Tween 20), the
blot was incubated overnight at 4∘Cwith primary antibodies:
polyclonal antibodies against human PIP5K1𝛼, PLC-𝛾1, E-
cadherin, p120-catenin, or transglutaminase 1 (Santa Cruz
Biotechnology, Inc., CA) at a dilution of 1 : 200, monoclonal
antibody against human 𝛽-catenin (Santa Cruz Biotechnol-
ogy, Inc., CA) at a dilution of 1 : 200, antibody against PP1𝛼,
𝛽, and 𝛾 (Santa Cruz Biotechnology, Inc., CA), polyclonal
antibody against keratin 1 or keratin 5 (Covance Research
Products, Inc., PA) at a dilution of 1 : 10000, monoclonal
antibody against human involucrin (Sigma Aldrich Corpo-
ration, MO) at a dilution of 1 : 2000, polyclonal antibody
against human p85 (Upstate Biotechnology, Inc., NY) which
is the regulatory subunit of class Ia PI3K at a dilution of
1 : 1000, and monoclonal antibodies against human integrin
2 (plasma membrane marker), BIP (endoplasmic reticulum
marker), or GM130 (cis-Golgi marker) at a dilution of 1 : 250
(BD Bioscience, CA). Then, the membranes were washed
a few times and then incubated for 1 hour with anti-IgG
secondary antibody conjugated to horseradish peroxidase
(Amersham Biosciences Corp., NJ) in the blocking buffer.
After another series of washes, bound antibody complexes
were visualized using the Supersignal Ultra Chemilumines-
cent Kit (Pierce Biotechnology, Inc.) and exposed to X-ray
film. To analyze protein complex formation at the plasma
membrane by coimmunoprecipitation, equal amounts of
plasma membrane protein (500 𝜇g) extracted with Mem-
PER Eukaryotic Membrane Protein Extraction Reagent Kit
were incubated with 2 𝜇g polyclonal antibody against E-
cadherin for 1 hour at room temperature or overnight at
4∘C and then with 20𝜇L UltraLink Immobilized Protein
A/G (Pierce Biotechnology, Inc.) for one hour at 4∘C.
After a series of washes, western analysis was done against
PIP5K1𝛼.
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2.4. PIP5K1𝛼 Activity Assay. PIP5K1𝛼 activity was deter-
mined in accordancewith themethod as previously described
by Chong et al. [45]. This method detects PIP
2
formation
from PI4P. The cells in 100mm dishes were washed thrice
with ice-cold PBS and extracted in Kinase Buffer (25mM
Tris/HCl, pH 7.4, 5mMMgCl
2
, 1 mM EDTA, 0.1mM EGTA,
1mM dithiothreitol, 150mM NaCl, 10% glycerol, 1% NP-40,
AEBSF, Roche complete protease inhibitors, and Roche Phos-
phatase Inhibitor Cocktail Tablets). PIP5K1𝛼 was immune-
precipitated from the lysate containing 500𝜇g protein using
2 𝜇g polyclonal antibody against PIP5K1𝛼 for 1 hour at 4∘C
and then 20𝜇LUltraLink ImmobilizedProteinA/G for 1 hour
at 4∘C.After a fewwashes, 10 𝜇L conjugated beadsweremixed
with 50 𝜇L Kinase Buffer containing sonicated phospholipids
(70 𝜇MPI4P and 35 𝜇M phosphatidylserine, final concentra-
tions) and preincubated for 15min at 25∘C. Reactions were
started by the addition of 20𝜇M [𝛾-32P] ATP (1 𝜇Ci/assay).
After incubation for 5min at 25∘C, 0.3mL of methanol,
1 N HCl (1 : 1, v/v) was added and extracted with 0.25mL
of chloroform. The organic layer was dried, resuspended
in chloroform, and chromatographed on oxalate-pretreated
Silica Gel 60 plates. Plates were developed in chloroform:
methanol: 2.5N ammonium hydroxide at a ratio of 9 : 7 : 2 by
volume and then the [32P]-labeled products were observed by
autoradiography.
2.5. Statistical Analysis. Data were analyzed by Student’s
paired 𝑡-test for data comparison of paired samples and
analysis of variance with a post hoc test for more groups
using SPSS 16.0. The data are presented as mean ± SD
of three separate experiments. The results are expressed as
percentages of the values in the control lane (presence of
0.03mM Ca2+ and control siRNA). A probability (𝑝) value
of less than 0.05 was considered statistically significant (∗𝑝 <
0.05).
3. Results
3.1. Calcium Induces PIP5K1𝛼 Dephosphorylation. To deter-
mine the upstream regulatory mechanism by which calcium
activates PIP5K1𝛼 and its role in keratinocyte differentiation,
human keratinocytes were treated with 1.2mM calcium
and harvested at 0, 5, 15, 30, 120, 240, and 360 minutes.
The plasma membrane and total cell lysates were isolated.
The results show that calcium treatment caused increased
serine dephosphorylation of PIP5K1𝛼 as early as 5 minutes
(Figure 1).
3.2. Knockdown of Phosphoprotein Phosphatase 1 (PP1) Blocks
Calcium-Induced PIP5K1𝛼 Dephosphorylation, Calcium-
Induced PIP5K1𝛼 Activity, and Calcium-Induced Keratinocyte
Differentiation. To determine whether PP1 plays a role
in calcium-induced keratinocyte differentiation, normal
human keratinocytes were pretreated with siRNA for PP1𝛼,
𝛽, and 𝛾 for 3 days and then exposed to 1.2mM calcium for
24 hours. Cells were harvested and total lysates were isolated.
Protein levels of PP1𝛼, 𝛽, and 𝛾 were determined to assess
knockdown efficiency. The results show specific knockdown
0 36024012030155
Total cell lysate
Ca2+ (1.2mM, min)
p-PIP5K1𝛼 (serine)
PIP5K1𝛼
Figure 1: Calcium induces PIP5K1𝛼 dephosphorylation. Human
keratinocytes cultured with 1.2mM and harvested at time points
indicated and analyzed by western analysis.
of the different PP1s by the specific mRNAs (Figure 2). No
compensation by the other PP1 isoforms was seen when one
was knocked down. To determine the role of PP1 knockdown
in calcium-induced PIP5K1𝛼 activation, cultured normal
human keratinocytes were treated with siRNA for PP1𝛼, 𝛽,
and 𝛾 for 3 days and then with calcium for 5min. Cells were
harvested and total cell lysates were isolated for PIP5K1𝛼
activity assay by measuring PIP
2
formation. The results
showed that knockdown of any of the three isoforms of PP1
blocked calcium-induced PIP5K1𝛼 activation (Figure 3). The
finding that any one PP1 isoform has identical effects on
inhibiting PIP5K1𝛼 might be because all three subunits of
PP1 form a complex and blocking of any one would disrupt
the complex.
Protein levels of differentiation markers, keratin 1
(early differentiation marker), involucrin, and transglutam-
inase (mid-differentiation markers), in normal human ker-
atinocytes in which PP1 was reduced were evaluated (Fig-
ure 4).The results showed that calcium-induced expression of
all of these markers was blocked.These data indicate that PP1
is required for calcium-induced keratinocyte differentiation.
3.3. Calcium Induces PP1 Recruitment to E-Cadherin in the
Plasma Membrane of Human Keratinocytes. In our previous
studies [19], we showed that the role of PIP5K1𝛼 recruited
by the E-cadherin-catenin complex to the plasma membrane
in calcium-induced keratinocyte differentiation provides the
substrate PIP
2
for both PI3K and PLC-𝛾1. This pathway
is critical for calcium-induced generation of the second
messengers IP
3
and intracellular calcium and keratinocyte
differentiation. To determine whether high calcium induces
recruitment of PP1 to the E-cadherin-𝛽-catenin-PIP5K1𝛼
complex in the plasma membrane, human keratinocytes
were treated with 1.2mM calcium for 5 minutes, and total
cell lysates and plasma membrane lysates were isolated.
The protein levels of E-cadherin, PIP5K𝛼, and PP1 were
determined by western analysis. The results showed that
calcium exposure for 5 minutes increased the expression of
E-cadherin, PIP5K𝛼, and PP1 in the plasmamembrane lysate,
but the expression levels of these proteins were not changed
in the total cell lysate. Of the organellar markers tested, only
the plasma membrane marker integrin 𝛼2 immunoreacted
with the plasma membrane lysate (Figure 5(a)). This fur-
ther documents the purity of the plasma membrane lysate
preparation. To demonstrate an interaction of PP1 with E-
cadherin in the plasma membrane, the plasma membrane
lysates were immunoprecipitated with E-cadherin antibody.
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Figure 2: Knockdown of PP1 blocks calcium-induced PIP5K1𝛼 dephosphorylation. Cultured human keratinocytes were treated with PP1𝛼
siRNA, PP1𝛽 siRNA, and PP1𝛾 siRNA for 72 hours and then with calcium for 5min. (a) Cells were harvested and protein levels of PP1𝛼, PP1𝛽,
and PP1𝛾 were determined by western analysis. (b) Data expressed are mean ± SD of three separate experiments, ∗𝑝 < 0.05.
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Figure 3: Knockdown of PP1 blocks calcium-induced PIP5K1𝛼 activity. Cultured human keratinocytes were treated with siRNA for PP1
for 72 hours and then with calcium for 5min. Cells were harvested and total cell lysates were isolated for PIP5K1𝛼 activity assay. (a)
The autoradiograph shown is from a representative experiment repeated thrice with three separate siRNA treatments. (b) The PIP
2
signal
intensities were quantitated by Image Pro Plus Software and normalized to band intensities of PIP5K1𝛼 in the corresponding western blot.
Results are expressed as percentages of the values in the control lane (the presence of 0.03mM calcium and control siRNA). Data expressed
are mean ± SD of three separate experiments, ∗𝑝 < 0.05 (significantly different from the control in the presence of 0.03mM calcium and
siRNA).
Western analysis of the immunoprecipitate with antibod-
ies against PP1 or PIP5K𝛼 showed their association with
E-cadherin. Taken together, our results indicate that PP1
is recruited to the calcium-dependent E-cadherin-catenin-
PIP5K1𝛼 complex in the plasma membrane to activate
PIP5K1𝛼, which is required for PLC-𝛾1 activation for ker-
atinocyte differentiation (Figure 5(b)).
3.4. Inhibition of PI3K, PLC, or PKC Activity Blocks Calcium-
Induced PIP5K1𝛼 Dephosphorylation and Calcium-Induced
PIP5K1𝛼 Activity. Cultured human keratinocytes were
treated with inhibitors for PI3K (LY29004, 10 𝜇M), PLC
(U73122, 3𝜇M), or PKC (GF109203, 2 𝜇M) for 72 hours and
then with calcium for 5min. Cells were harvested and total
cell lysates were isolated for the PIP5K1𝛼 activity assay. The
results showed that inhibition of PI3K, PLC, or PKC activity
blocked calcium-induced PIP5K1𝛼 dephosphorylation and
calcium-induced PIP5K1𝛼 activation (Figures 6 and 7).
3.5. Knockdown of E-Cadherin/Catenins or PLC-𝛾1 Blocks
Calcium-Induced PIP5K1𝛼 Dephosphorylation and Calcium-
Induced PIP5K1𝛼 Activation. Cultured human keratinocytes
were treated with siRNA for E-cadherin, 𝛽-catenin, p120,
or PLC-𝛾1 for 3 days and then exposed to calcium for
BioMed Research International 5
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Figure 4: Knockdown of PP1 blocks calcium-induced keratinocyte differentiation. Cultured human keratinocytes were treated with PP1𝛼
siRNA, PP1𝛽 siRNA, and PP1𝛾 siRNA for 72 hours and then in calcium for 5min. Cells were harvested and total cell lysates were isolated. (a)
The protein levels of PP1𝛼, PP1𝛽, PP1𝛾, keratin 1, involucrin, and transglutaminase were determined by western analysis. (b) Data expressed
are mean ± SD of three separate experiments, ∗𝑝 < 0.05.
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Figure 5: Calcium induces PP1 recruitment to E-cadherin in the plasma membrane. (a) Cultured human keratinocytes were treated with
1.2mM calcium for 5min. Cells were harvested and the protein levels of PP1𝛼, PP1𝛽, PP1𝛾, PIP5K1𝛼, E-cadherin, integrin 𝛼2 (plasma
membrane marker), BIP (endoplasmic reticulum marker), and GM130 (cis-Golgi marker) in total cell lysate and plasma membrane lysate
were determined by western analysis. The results are from a representative experiment that was repeated three times. (b)The total cell lysates
and the plasma cell lysates were isolated and analyzed by immunoprecipitation (IP) with antibody against E-cadherin followed by western
analysis with antibodies against PP1𝛼, PP1𝛽, PP1𝛾, PIP5K1𝛼, and E-cadherin.
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Figure 6: Inhibition of PI3K, PLC, or PKC activity blocks
calcium-induced PIP5K1𝛼 dephosphorylation. Cultured human
keratinocytes were treated with inhibitors for PI3K, PLC, and PKC
for 72 hours and then with calcium for 5min. Cells were harvested
and then analyzed by western analysis.
5min. Cells were harvested and total cell lysates were
isolated. The protein levels of E-cadherin, 𝛽-catenin, p120,
PLC-𝛾1, p-PIP5KI𝛼 (serine), and PIP5KI𝛼 were analyzed
by western analysis. The results showed that knockdown
of E-cadherin/catenin or PLC-𝛾1 blocked calcium-induced
PIP5K1𝛼 dephosphorylation (Figure 8). To determine
whether high calcium induces PIP5K1𝛼 activity, cultured
human keratinocytes were treated with 1.2mM calcium for
5–360min (Figure 9). Cells were harvested and total cell
lysates were isolated for PIP5K1𝛼 activity assay. Consistent
with an increase in PIP
2
level, calcium induced PIP5K1𝛼
activity in a time-dependent manner. Then, we wanted to
know whether E-cadherin, 𝛽-catenin, and PLC-𝛾1 were
required for the activation of PIP5K1𝛼. To address this issue,
E-cadherin, 𝛽-catenin, or PLC-𝛾1 was knocked down by
siRNA before calcium treatment. Cells were harvested, and
total cell lysates were isolated for PIP5K1𝛼 activity assay. The
results showed that E-cadherin or 𝛽-catenin knockdown
blocked calcium-induced PIP5K1𝛼 activation. In addition,
knockdown of PLC-𝛾1, the downstream effector of PIP5K1𝛼,
in these cells blocked upstream dephosphorylation and
activation of PIP5K1𝛼 induced by calcium. These data
indicate that E-cadherin, 𝛽-catenin, and PLC-𝛾1 are required
for calcium-induced PIP5K1𝛼 activation.
4. Discussion
Protein phosphatase and kinase enzymes together with
changes in intracellular calcium have been shown to possess
significant roles in regulation of cell differentiation.We know
that PIP5K1𝛼 activation is an important step in calcium-
induced keratinocyte differentiation. In this study, we show
that PP1 plays a role in calcium-induced keratinocyte dif-
ferentiation, and it also mediates calcium-induced PIP5K1𝛼
activation and dephosphorylation. Under high calcium con-
centration, PP1 is recruited to the E-cadherin-𝛽-catenin-
p120 catenin complex. This study further shows that the
signaling pathway involves the E-cadherin/𝛽-catenin/p120
catenin complex, PKC, PLC-𝛾1, and PI3K, via PIP5K1𝛼
activation. It is possible, therefore, to speculate that high
calcium induces formation of the E-cadherin-𝛽-catenin-p120
catenin complex and subsequently recruits PIP5K1𝛼, PI3K,
and PP1.
The model for this process is as follows. Calcium recruits
the E-cadherin-𝛽-catenin-p120-catenin (p120) complex to
the plasma membrane (Figure 10).The complex then recruits
and activates PI3K leading to PIP
3
accumulation, which
recruits and activates PLC-𝛾1. PLC-𝛾1 hydrolyzes PIP
2
to IP
3
to trigger keratinocyte differentiation by stimulating calcium
release from the endoplasmic reticulum and Golgi thereby
increasing the intracellular calcium level. PIP5K1𝛼 is also
recruited to the E-cadherin-𝛽-catenin complex where it is
activated by PLC-𝛾1/PKC dependent PP1 via a feed-forward
mechanism to continuously supply the substrate PIP
2
for
both PLC-𝛾1 and PI3K. In other words, PP1 is recruited to the
calcium-dependent E-cadherin-𝛽-catenin-PIP5K1𝛼 complex
in the plasma membrane to activate PIP5K1𝛼. This increases
the synthesis of the substrate PIP
2
for both PLC-𝛾1 and
PI3K. PLC-𝛾1 hydrolyzes PIP
2
to IP
3
. This increases calcium
concentration, which leads to keratinocyte differentiation.
Previous studies have shown the roles of PIP5K1𝛼, PLC-
𝛾1, and PI3K in mediating calcium-induced differentiation
[16–19]. PIP5K1𝛼 converts PIP to PIP
2
, and PI3K converts
PIP
2
to PIP
3
. This PIP
3
, in turn, activates PLC-𝛾1, which
enhances the hydrolysis of PIP
2
to IP
3
and DAG. In the
present study, we further explore the role of PP1 in calcium-
induced differentiation via inducing activation and dephos-
phorylation of PIP5K1𝛼.
There are two main ways by which calcium utilizes PP1
for its role in keratinocyte differentiation. The first one is as
follows: calcium binds to E-cadherin, which recruits PP1 to
the cell membrane. The second one could be the signaling
pathway inwhichDAGactivates PKC, which in turn activates
PP1 that further brings about the dephosphorylation and
activation of PIP5K1𝛼. Our previous studies have shown
that the activation of PIP5K1𝛼 plays an important role in
differentiation of keratinocytes. The present study shows the
role of PP1 in keratinocyte differentiation, also via PIP5K1𝛼
activation. This could be one novel addition to the mecha-
nism by which calcium induces keratinocyte differentiation.
Intracellular calcium rise is necessary for keratinocyte
differentiation [26].The transient rise of intracellular calcium
is not enough for keratinocyte differentiation, possibly due
to the activation of PLC-𝛽 [39], whereas the sustained rise
in intracellular calcium is required to induce differentiation
possibly via activating PLC-𝛾1 [26]. Sustained increased levels
of intracellular calcium can be achieved by the increase in
the extracellular calcium level [24, 25] via the aforementioned
pathway and store-operated calcium channels [46–48]. The
roles of PIP
2
and calcium in activating store-operated calcium
entry have been put forward in a study in platelets [46]
and that of PLC-𝛾1 has been put forward for the same in
studies in liver cells [47] and keratinocytes [48]. PIP
2
activates
the downstream signaling leading to differentiation. High
extracellular calcium concentration leads to PI3K recruit-
ment to the E-cadherin-catenin complex [18, 49] and also the
recruitment of PIP5K𝛼 [19] via 𝛽-catenin.
Various studies have shown conflicting results regarding
the role of PP1 in tumor progression. A study by Kohno et
al. shows the presence of PPP1R3 gene encoding the PP1
regulatory subunit in myriad human cancers, and there is a
possibility of this gene being a tumor suppressor gene [50]
because PP1𝛼 can dephosphorylate and activate the tumor
suppressor gene, pRB [51]. In contrast, other studies depict
PP1𝛼 as having an oncogenic effect, brought about by the
dephosphorylation of breast and ovarian tumor suppressor
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Figure 7: Inhibition of PI3K, PLC, or PKC activity blocks calcium-induced PIP5K1𝛼 activity. Cultured human keratinocytes were treated
with inhibitors for PI3K, PLC, and PKC for 72 hours and then with calcium for 5min. Cells were harvested and total cell lysates were isolated
for PIP5K1𝛼 activity assay. (a) The autoradiograph shown is from a representative experiment repeated thrice with three separate siRNA
treatments. (b) The PIP
2
signal intensities were quantitated by Image Pro Plus Software and normalized to band intensities of PIP5K1𝛼 in
the corresponding western blot. Results are expressed as percentages of the values in the control lane (the presence of 0.03mM calcium and
control siRNA). Data expressed asmean± SD of three separate experiments, ∗𝑝 < 0.05 (significantly different from the control in the presence
of 0.03mM calcium and siRNA).
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Figure 8: Knockdown of E-cadherin/catenins or PLC-𝛾1 blocks calcium-induced PIP5K1𝛼 dephosphorylation. Cultured human ker-
atinocytes were treated with E-cadherin siRNA, 𝛽-catenin siRNA, p120 siRNA, and PLC-𝛾1 siRNA for 72 hours and then in calcium for
5min. Cells were harvested and total cell lysates were isolated.The protein levels of E-cadherin, 𝛽-catenin, p120, PLC-𝛾1, p-PIP5KI𝛼 (serine),
and PIP5KI𝛼 were analyzed by western analysis. Data expressed are mean ± SD of three separate experiments, ∗𝑝 < 0.05.
protein BRCA1. Furthermore, the overexpression and/or
increase in PP1 activity is associated with accelerated growth
of malignant cells [52, 53]. Our present study shows that PP1
mediates calcium-induced differentiation in keratinocytes,
suggesting the possible role of PP1 in tumor suppression.
According to the results of our previous experiments, we
found that the staining of the intracellular protein in ker-
atinocytes is as sensitive as western blotting (Figure 4), so
PIP5K1𝛼 staining on keratinocytes was not performed. In
contrast to our findings, a study by Hsu et al. has shown
that PP1 plays a role in tumorigenesis and progression of
oral squamous carcinoma cells [54]. This study also shows
that different oral squamous carcinoma cell lines have various
levels of PP1𝛼, which may define the rate of proliferation.The
higher the PP1𝛼 level, the faster the proliferation. Knockdown
of PP1𝛼 inhibits proliferation [54]. We believe that the
differences between our results and the study by Hsu et al.
arise, because of the different localization of PP1 distribution
and the influence of various factors including calcium in the
regulation of PP1 distribution [55, 56]. PP1 is localized in the
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Figure 10:Theproposedmodel. A proposedmodel for the signaling pathway of calcium-induced keratinocyte differentiation. In high calcium
conditions, PP1 is recruited to the calcium-dependent E-cadherin-𝛽-catenin-PIP5K1𝛼 complex in the plasmamembrane to activate PIP5K1𝛼,
which increases the synthesis of the substrate PIP
2
for both PLC-𝛾1 and PI3K. PLC-𝛾1 hydrolyzes PIP
2
to IP
3
, which in turn increases calcium
concentration leading to keratinocyte differentiation.
plasma membrane, nucleus, and cytoplasm and has distinct
site-specific roles [55, 57], but further localization studies
should be done to explain the differences in the regulation
and function of PP1.
In the present study, calcium recruits PP1 to the plasma
membrane and aids in cell differentiation.Our previous study
had shown that calcium has a protective role against oral
squamous cell carcinoma [58]. Further research has to be
done on the possible impact of the localization of PP1 on
malignancy. But, only a very small fraction of PP1 would
likely be recruited to the plasma membrane. PP1 is in over
a hundred different complexes throughout the cell and any
particular pathway will only involve a particular complex,
which represents only a small pool of total cellular PP1.
Few studies have studied the effects of the knockdown
of the components of the E-cadherin complex, to effects on
keratinocyte marker expression [59, 60].
5. Conclusion
Phosphoprotein phosphatase 1 is required for calcium-
induced PIP5K1𝛼 activation and keratinocyte differentiation.
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